Barclays’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Buy |
40,005
+15,704
| +65% | +$130K | ﹤0.01% | 3258 |
|
|
2025
Q1 | $148K | Sell |
24,301
-11,371
| -32% | -$69.3K | ﹤0.01% | 3488 |
|
|
2024
Q4 | $225K | Buy |
35,672
+4,353
| +14% | +$27.5K | ﹤0.01% | 3461 |
|
|
2024
Q3 | $157K | Buy |
31,319
+22,951
| +274% | +$115K | ﹤0.01% | 3593 |
|
|
2024
Q2 | $52K | Sell |
8,368
-4,508
| -35% | -$28K | ﹤0.01% | 3664 |
|
|
2024
Q1 | $143K | Sell |
12,876
-12,199
| -49% | -$135K | ﹤0.01% | 3501 |
|
|
2023
Q4 | $282K | Buy |
25,075
+21,615
| +625% | +$243K | ﹤0.01% | 3355 |
|
|
2023
Q3 | $26K | Sell |
3,460
-175
| -5% | -$1.32K | ﹤0.01% | 3830 |
|
|
2023
Q2 | $32K | Sell |
3,635
-6,062
| -63% | -$53.4K | ﹤0.01% | 3855 |
|
|
2023
Q1 | $81K | Buy |
9,697
+437
| +5% | +$3.65K | ﹤0.01% | 3628 |
|
|
2022
Q4 | $89K | Buy |
+9,260
| New | +$89K | ﹤0.01% | 3525 |
|
|
2021
Q4 | – | Sell |
-2,648
| Closed | -$25K | – | 3417 |
|
|
2021
Q3 | $25K | Sell |
2,648
-346
| -12% | -$3.27K | ﹤0.01% | 3576 |
|
|
2021
Q2 | $21K | Sell |
2,994
-15,200
| -84% | -$107K | ﹤0.01% | 3702 |
|
|
2021
Q1 | $113K | Buy |
18,194
+11,170
| +159% | +$69.4K | ﹤0.01% | 3331 |
|
|
2020
Q4 | $53K | Sell |
7,024
-2,779
| -28% | -$21K | ﹤0.01% | 3155 |
|
|
2020
Q3 | $60K | Sell |
9,803
-2,162
| -18% | -$13.2K | ﹤0.01% | 3209 |
|
|
2020
Q2 | $100K | Buy |
+11,965
| New | +$100K | ﹤0.01% | 3123 |
|
|
2019
Q3 | – | Sell |
-543
| Closed | -$2K | – | 4209 |
|
|
2019
Q2 | $2K | Sell |
543
-2,873
| -84% | -$10.6K | ﹤0.01% | 4138 |
|
|
2019
Q1 | $17K | Buy |
+3,416
| New | +$17K | ﹤0.01% | 3940 |
|
|
2018
Q4 | – | Sell |
-4,631
| Closed | -$38K | – | 4178 |
|
|
2018
Q3 | $38K | Buy |
4,631
+3,801
| +458% | +$31.2K | ﹤0.01% | 3809 |
|
|
2018
Q2 | $8K | Buy |
+830
| New | +$8K | ﹤0.01% | 3944 |
|